2015 EMSOS Book of Abstracts.Pdf 8.52 MB
Total Page:16
File Type:pdf, Size:1020Kb
Abstracts are published in the present Abstract Book as submitted by the authors. Missing presentation numbers represent abstracts withdrawn by the authors. Book of Abstracts • Page 2 Table of Contents Welcome Message ......................................................................................................................... 4 Organisation & Committees ............................................................................................................ 5 Free Communications .................................................................................................................... 6 FREE COMMUNICATIONS SESSION IA: Spino-Pelvis ................................................................................... 6 FREE COMMUNICATIONS SESSION IB: Spino-Pelvis ................................................................................. 11 FREE COMMUNICATIONS SESSION IIA: Oncology ................................................................................... 16 FREE COMMUNICATIONS SESSION IIB: Oncology ................................................................................... 20 FREE COMMUNICATIONS SESSION III: Upper Extremity .......................................................................... 24 FREE COMMUNICATIONS SESSION IV: Minimally Invasive Techniques-Biopsies ........................................... 29 FREE COMMUNICATIONS SESSION V: Metastatic Bone Disease ................................................................. 34 FREE COMMUNICATIONS SESSION VI: Skeletal Reconstruction ................................................................. 37 FREE COMMUNICATIONS SESSION VIIA: Allografts – Megaprostheses ....................................................... 39 FREE COMMUNICATIONS SESSION VIIB: Allografts – Megaprostheses ....................................................... 44 FREE COMMUNICATIONS SESSION VIIIA: Soft Tissue Tumors .................................................................. 48 FREE COMMUNICATIONS SESSION VIIIB: Soft Tissue Tumors .................................................................. 52 FREE COMMUNICATIONS SESSION IX: Cartilaginous Tumors .................................................................... 57 FREE COMMUNICATIONS SESSION X: Giant Cell Tumor of Bone ................................................................ 62 FREE COMMUNICATIONS SESSION XI: Pediatrics .................................................................................... 69 FREE COMMUNICATIONS SESSION XII: What’s New? .............................................................................. 76 FREE COMMUNICATIONS SESSION XIII: Miscellaneous – Quality of Life ..................................................... 82 Nurse Programme – Free Communications ..................................................................................... 89 NURSE PROGRAMME SESSION I: Free Communications ........................................................................... 89 NURSE PROGRAMME SESSION III: Free Communications ......................................................................... 90 Poster Presentations ..................................................................................................................... 93 POSTER PRESENTATIONS SESSION I: Complex Skeletal Reconstruction ..................................................... 93 POSTER PRESENTATIONS SESSION II: Expandable Prostheses in Children ................................................ 105 POSTER PRESENTATIONS SESSION III: Individualized Treatment ............................................................ 107 POSTER PRESENTATIONS SESSION IV: Massive Bone Defects: What’s the Best Reconstructive Option ......... 118 POSTER PRESENTATIONS SESSION V: Minimally Invasive Treatments ...................................................... 127 POSTER PRESENTATIONS SESSION VI: Pediatric Sarcomas .................................................................... 139 POSTER PRESENTATIONS SESSION VII: New Rankl Inhibitors for Bone Loss in MM, MBD and GCT .............. 143 POSTER PRESENTATIONS SESSION VIII: Novel Therapeutics in Sarcoma: New Targets, New Agents ........... 146 POSTER PRESENTATIONS SESSION IX: Spine and Sacral Tumors ............................................................ 148 POSTER PRESENTATIONS SESSION X: Computer-Assisted Navigation and Musculoskeletal Tumor ................ 152 POSTER PRESENTATIONS SESSION XI: Complications in Sarcoma Treatment; How to Avoid and Treat ......... 153 POSTER PRESENTATIONS SESSION XII: Vascular, Lipomatous and Desmoid Tumors ................................. 160 POSTER PRESENTATIONS SESSION XIII: What’s New in Musculoskeletal Oncology .................................... 169 POSTER PRESENTATIONS SESSION XIV: New WHO Classification of Bone and Soft Tissue .......................... 184 POSTER PRESENTATIONS SESSION XV: Various ................................................................................... 186 Index of Authors ........................................................................................................................ 194 Book of Abstracts • Page 3 Welcome Message Dear friends, The European Musculo-Skeletal Oncology Society (EMSOS) aims at advancing the science and practice of the diagnosis and treatment of bone and soft tissue tumors, to promote basic and clinical research, and to disseminate knowledge in order to provide a common high standard of musculo-skeletal oncology. The particular purpose of the Society is to promote mutual collaboration between different specialists and institutes involved in the treatment of musculo-skeletal tumors. The format of the meeting ensures not only a highly educational experience, but also ample networking and practice exchange opportunities. The EMSOS 2015 Organizing Committee is enthusiastic to have developed a scientifically prolific programme, which is expected to cover all aspects of Musculoskeletal Oncology bringing together experts from all disciplines related to the field. We anticipate your active participation, as members of the global Musculoskeletal Oncology community, for the success of the 28th EMSOS Annual Meeting. Welcome to Athens! With warm regards, Panayiotis J. Papagelopoulos, MD, DSc Local Host, EMSOS 2015 Professor & Chairman, Department of Orthopaedics, Athens University Medical School & ATTIKON University General Hospital Athens, Greece Book of Abstracts • Page 4 Organisation & Committees EMSOS Executive Board President: Stefano Ferrari (Italy) Vice President: Georg Gosheger (Germany) Past President: Robert Grimer (United Kingdom) Secretary: Andreas Leithner (Austria) Treasurer: Georg Gosheger (Germany) EMSOS 2015 Organizing Committee President: Panayiotis J. Papagelopoulos (Greece) Secretary: Andreas F. Mavrogenis (Greece) EMSOS 2015 Scientific Committee Albert Aboulafia (USA) Allessandro Gronchi (Italy) Elizabeth Patiraki (Greece) Giuseppe Bianchi (Italy) Wei Guo (China) Piero Picci (Italy) Stefan Bielack (Germany) John Healy (USA) Pietro Ruggieri (Italy) Steven Cannon (United Kingdom) Carrie Inwards (USA) Franklin Sim (USA) Rodolfo Capanna (Italy) Rainer Kotz (Austria) Antonie Taminiau (The Netherlands) Davide Donati (Italy) Nicolette Leijerzapf (The Netherlands) Miklos Szendroi (Hungary) Nicola Fabbri (USA) Andreas Leithner (Austria) Antonie Taminiau (The Netherlands) Stefan Ferrari (Italy) Luis Muscolo (Argentina) Robert Turcotte (Canada) Evanthia Galanis (USA) Berlin Orjan (Sweden) Doris Wenger (USA) Georg Gosheger (Germany) Andreas Mavrogenis (Greece) Reinhard Windhager (Austria) Francois Gouin (France) Panayiotis Papaggelopoulos Jay Wunder (Canada) Robert Grimer (United Kingdom) (Greece) EMSOS 2015 Supporting Organisations British Orthopaedic Association The Connective Tissue Oncology Society (CTOS) European Federation of National Associations of Orthopaedics and Traumatology (EFORT) European Oncology Nursing Society (EONS) European Society for Medical Oncology (ESMO) European Society for Radiotherapy and Oncology (ESTRO) Hellenic Society of Radiation Oncology Hellenic Association of Orthopaedic Surgery and Traumatology (HAOST) Book of Abstracts • Page 5 Free Communications FREE COMMUNICATIONS SESSION IA: Introduction: Parosteal osteosarcoma (POS) is a rare, Spino-Pelvis low-grade malignant bone tumour. Accounting for 4-6% of all osteosarcomas it most is most commonly located in the posterior distal femur. The aim of this single centre FC-001 retrospective study was to evaluate the clinical features Outcome of pelvic/sacral resection and and surgical outcomes of patients with POS. reconstruction for bone tumors Methods: This retrospective study comprised 80 patients A. Shehadeh diagnosed with POS identified from the oncology database King Hussein Cancer Center, Amman, Jordan at the Royal Orthopedic Hospital, Birmingham, UK between 1968 and 2014. 1782 cases of osteosarcoma Background: The pelvic girdle is a common location for were identified, with POS representing 4.5% of the total primary bone sarcomas and metastatic lesions with the osteosarcoma burden. Patient survival was assessed using periacetabular region being the most common location the Kaplan-Meier method from the date of diagnosis using followed by the ilium and the pubis. Refinements in a log-rank test for univariate analysis, whilst a Cox surgical techniques have allowed the execution of limb regression analysis was used to identify independent salvage surgery in these locations. factors affecting patient survival. Methods and Materials: Twelve patients